Dexmedetomidine for reducing succinylcholine-induced myalgia in patients undergoing electroconvulsive therapy: A randomised controlled trial.

Bhavna Sriramka Sasmita Panigrahy Mathan Kumar Ramasubbu Suvendu N Mishra

Published in: Indian journal of anaesthesia (2024)

A low dose of dexmedetomidine (0.25 µg/kg) effectively reduces myalgia and fasciculations due to succinylcholine in patients undergoing electroconvulsive therapy.

Keyphrases

patients undergoing
low dose
cardiac surgery
high glucose
high dose
diabetic rats
drug induced